Cedar Grove Medical Associates,llc
Cedar Grove Medical Associates,llc was paid $530K by Medicaid between Jan 2018 and Dec 2024, across 26 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoCEDAR GROVE MEDICAL ASSOCIATES,LLC
SMYRNA, TN 37167
SMYRNA, TN 37167
33aNPI1558564021assigned 06/11/2007
33bProvider typeSpecialist
28Total paid$530K
24GClaims25,014
24DCodes billed26
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Tennessee
Rank by total paid#47 of 252
Median peer was paid$57K
This provider vs. median9.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,473 | $96K | |
| 2019 | 4,449 | $101K | |
| 2020 | 3,648 | $72K | |
| 2021 | 3,253 | $73K | |
| 2022 | 3,302 | $64K | |
| 2023 | 3,619 | $73K | |
| 2024incomplete | 2,270 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 7,915 | 6,682 | $267K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 4,521 | 3,607 | $199K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 202 | 184 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 820 | 671 | $8K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.1% | 297 | 248 | $6K |
| 90756 | 1.0% | 254 | 235 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,096 | 3,504 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 416 | 369 | $4K |
| 80305 | <1% | 827 | 646 | $4K | |
| 90686 | <1% | 451 | 385 | $4K | |
| 92552 | <1% | 242 | 201 | $4K | |
| 81003 | <1% | 2,549 | 2,135 | $3K |
14 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 381 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 391 | $3K |
| 96160 | <1% | 323 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 162 | $1K |
| 96127 | <1% | 355 | $1K | |
| 99173 | <1% | 275 | $750.55 | |
| 90661 | <1% | 26 | $616.09 | |
| 96161 | <1% | 143 | $536.50 | |
| 97802 | <1% | 12 | $136.31 | |
| 85018 | <1% | 81 | $107.19 | |
| 36416 | <1% | 175 | $61.20 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 31 | $11.15 |
| 99000 | 0% | 46 | $0.00 | |
| 94760 | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUDD, JOHN (OWNER)